Authors:
Khuri, FR
Wu, H
Lee, JJ
Kemp, BL
Lotan, R
Lippman, SM
Feng, L
Hong, WK
Xu, XC
Citation: Fr. Khuri et al., Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer, CLIN CANC R, 7(4), 2001, pp. 861-867
Authors:
Tang, XM
Khuri, FR
Lee, JJ
Kemp, BL
Liu, D
Hong, WK
Mao, L
Citation: Xm. Tang et al., Hypermethylation of the death-associated protein (DAP) kinase promoter andaggressiveness in stage I non-small-cell lung cancer, J NAT CANC, 92(18), 2000, pp. 1511-1516
Authors:
Kurie, JM
Lee, JS
Khuri, FR
Mao, L
Morice, RC
Lee, JJ
Walsh, GL
Broxson, A
Lippman, SM
Ro, JY
Kemp, BL
Liu, D
Fritsche, HA
Xu, XC
Lotan, R
Hong, WK
Citation: Jm. Kurie et al., N-(4-hydroxyphenyl)retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium, CLIN CANC R, 6(8), 2000, pp. 2973-2979
Authors:
Wang, L
Lin, SH
Wu, WG
Kemp, BL
Walsh, GL
Hong, WK
Mao, L
Citation: L. Wang et al., C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers, CLIN CANC R, 6(8), 2000, pp. 2988-2993
Authors:
Yen, N
Ioannides, CG
Xu, K
Swisher, SG
Lawrence, DD
Kemp, BL
El-Naggar, AK
Cristiano, RJ
Fang, BL
Glisson, BS
Hong, WK
Khuri, FR
Kurie, JM
Lee, JJ
Lee, JS
Merritt, JA
Mukhopadhyay, T
Nesbitt, JC
Nguyen, D
Perez-Soler, R
Pisters, KMW
Putnam, JB
Schrump, DS
Shin, DM
Walsh, GL
Roth, JA
Citation: N. Yen et al., Cellular and humoral immune responses to adenovirus and p53 protein antigens in patients following intratumoral injection of an adenovirus vector expressing wild-type p53 (Ad-p53), CANC GENE T, 7(4), 2000, pp. 530-536
Authors:
Nemunaitis, J
Swisher, SG
Timmons, T
Connors, D
Mack, M
Doerksen, L
Weill, D
Wait, J
Lawrence, DD
Kemp, BL
Fossella, F
Glisson, BS
Hong, WK
Khuri, FR
Kurie, JM
Lee, JJ
Lee, JS
Nguyen, DM
Nesbitt, JC
Perez-Soler, R
Pisters, KMW
Putnam, JB
Richli, WR
Shin, DM
Walsh, GL
Merritt, J
Roth, J
Citation: J. Nemunaitis et al., Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumorsof patients with non-small-cell lung cancer, J CL ONCOL, 18(3), 2000, pp. 609-622
Authors:
Khuri, FR
Lotan, R
Kemp, BL
Lippman, SM
Wu, H
Feng, L
Lee, JJ
Cooksley, CS
Parr, B
Chang, E
Walsh, GL
Lee, JS
Hong, WK
Xu, XC
Citation: Fr. Khuri et al., Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer, J CL ONCOL, 18(15), 2000, pp. 2798-2804
Citation: Rf. Munden et al., Radiologic-pathologic conferences of the university of Texas M. D. Anderson Cancer Center - Primary liposarcoma of the mediastinum, AM J ROENTG, 175(5), 2000, pp. 1340-1340
Citation: Wg. Wu et al., TRAIL-R2 is not correlated with p53 status add is rarely mutated in non-small cell lung cancer, ANTICANC R, 20(6B), 2000, pp. 4525-4529
Authors:
Wu, WG
Kemp, BL
Proctor, ML
Gazdar, AF
Minna, JD
Hong, WK
Mao, L
Citation: Wg. Wu et al., Expression of DMBT1, a candidate tumor suppressor gene, is frequently lostin lung cancer, CANCER RES, 59(8), 1999, pp. 1846-1851
Authors:
Tseng, JE
Kemp, BL
Khuri, FR
Kurie, JH
Lee, JS
Zhou, X
Liu, D
Hong, WK
Mao, L
Citation: Je. Tseng et al., Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers, CANCER RES, 59(19), 1999, pp. 4798-4803